Marcel P. M. Stokkel

The Netherlands Cancer Institute

Papers

5

Total Citations

72

H-Index

4

About

Dr. Marcel P. M. Stokkel is a leading nuclear medicine physician whose research has significantly advanced the use of molecular imaging in oncology, particularly for prostate and breast cancers. His most impactful work focuses on the clinical utility of PSMA PET/CT in primary prostate cancer staging. In a landmark 2020 study with 55 citations, Dr. Stokkel demonstrated that PSMA PET/CT offers superior accuracy over conventional imaging for nodal and distant staging, directly influencing clinical management decisions. This contribution has helped establish PSMA PET/CT as a critical tool in prostate cancer care. Beyond prostate cancer, Dr. Stokkel has pioneered high-precision biopsy techniques, developing a novel semi-robotized device for 18F-FDG-guided breast cancer biopsy, a notable achievement in image-guided interventions. He has also refined sentinel node localization in prostate cancer using SPECT/CT for anatomically challenging sites like pararectal and presacral nodes. Through these innovations, Dr. Stokkel has enhanced diagnostic precision and therapeutic guidance, making a lasting impact on nuclear oncology and personalized cancer management.

Research Focus

Key Achievements

4
H-Index
5
Papers
72
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study
55 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago